Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - copy of newspaper advertisement.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchange about newspaper advertisements published in Free Press Journal (English) and Navshakti (Marathi) on January 20, 2026, notifying shareholders about an upcoming EGM. The EGM will be held on Monday, February 16, 2026 at 9:00 AM through video conferencing. The sole agenda item is the appointment of Ms. Pooja Narendra Sanghavi (DIN: 11387388) as Non-Executive Independent Director. The EGM notice was emailed to shareholders on January 19, 2026. Remote e-voting will be available from February 13 to February 15, 2026, with February 9, 2026 set as the cut-off date to determine voting eligibility.
This is a routine regulatory compliance filing with no direct impact on stock price. The proposed appointment of a new Independent Director, if approved at the EGM, will strengthen the company's board composition and corporate governance.